Conditions: Non-small Cell Lung Cancer; Leptomeningeal Disease; Central Nervous System Metastases
Intervention: Drug: Afatinib
Sponsor: National Cancer Centre, Singapore
Not yet recruiting
Feeds
5336 items (5336 unread) in 74 feeds
Acinar Cell Carcinoma
(28 unread)
Acinic Cell Carcinoma
(24 unread)
Adenoid Cystic Carcinoma
(76 unread)
Adrenal Gland Cancer
(343 unread)
Ampulla Of Vater
(30 unread)
Anal Cancer
(584 unread)
Angiosarcoma
(75 unread)
Appendix Cancer
(59 unread)
Bile Duct Cancer
(641 unread)
Brain and CNS
(859 unread)
Carcinoid
(134 unread)
Endocrine/Neuroendocrine
(666 unread)
Gall Bladder Cancer
(123 unread)
Hemangioendothelioma
(41 unread)
Hepatoblastoma
(61 unread)
Pancreas
(43 unread)
Phyllodes
(48 unread)
PMP and Mucinous Tumors
(19 unread)
Rhabdomyosarcoma
(130 unread)
Sarcoma
(1352 unread)
Trial - Brain Tumor (100 unread)
-
Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
Posted: October 18th, 2018, 2:00pm GMT
-
The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat)
Posted: October 18th, 2018, 2:00pm GMT
Conditions: Meningitis; Encephalitis; Guillain-Barré; Subarachnoid Hemorrhage; Intracranial Neoplasm; Intracranial CNS Disorder
Intervention: Device: LPat Device
Sponsors: Spartanburg Regional Healthcare System; Edward Via Virginia College of Osteopathic Medicine
Recruiting -
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
Posted: October 17th, 2018, 2:00pm GMT
Conditions: Solid Tumors; Ewing Sarcoma; Rhabdoid Tumor; Rhabdomyosarcoma; Neuroblastoma; Medulloblastoma
Interventions: Drug: Palbociclib; Drug: Temozolomide; Drug: Irinotecan
Sponsor: Pfizer
Not yet recruiting -
Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
Posted: October 16th, 2018, 2:00pm GMT
Conditions: Glioblastoma; Glioblastoma Multiforme
Interventions: Drug: Nivolumab; Drug: Anti-GITR Monoclonal Antibody MK-4166; Drug: IDO1 inhibitor INCB024360; Drug: Ipilimumab
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Bristol-Myers Squibb
Not yet recruiting -
Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
Posted: October 15th, 2018, 2:00pm GMT
Conditions: Glioblastoma; Cancer of Brain; Glioblastoma Multiforme; Brain Tumor
Interventions: Device: Tumor Treating Fields; Drug: Temozolomide; Radiation: Radiation Therapy
Sponsors: Providence Health & Services; Providence Health & Services Brain & Spine Institute; University of California, San Francisco; NovoCure Ltd.
Not yet recruiting -
Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases
Posted: October 5th, 2018, 2:00pm GMT
Conditions: Brain Metastases; Glioma of Brain; Brain Tumor; Metastatic Melanoma
Interventions: Device: Dynamic Contrast-Enhanced Magnetic Resonance Imaging; Drug: Bevacizumab Injection
Sponsors: University of Southern California; National Cancer Institute (NCI)
Not yet recruiting -
Fractionated Stereotactic Radiotherapy vs. Single Session Radiosurgery in Patients With Larger Brain Metastases
Posted: October 5th, 2018, 2:00pm GMT
Condition: Cerebral Metastases of Solid Cancers
Interventions: Radiation: Radiosurgery; Radiation: Fractionated stereotactic radiotherapy
Sponsor: University of Erlangen-Nürnberg Medical School
Not yet recruiting -
Blood Biomarker Signature in Glioma
Posted: October 5th, 2018, 2:00pm GMT
Condition: Glioma of Brain
Intervention: Other: Non-interventional
Sponsors: Cancer Trials Ireland; Dublin City University
Recruiting -
Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer
Posted: October 5th, 2018, 2:00pm GMT
Condition: Breast Cancer
Intervention: Drug: 68Ga-OPS202
Sponsor: Ipsen
Not yet recruiting -
Phase I Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas
Posted: October 4th, 2018, 2:00pm GMT
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: GDC-0084; Radiation: radiation therapy
Sponsors: St. Jude Children's Research Hospital; Kazia Therapeutics Limited
Recruiting -
HER2-CAR T Cells in Treating Participants With Brain or Leptomeningeal Metastases
Posted: October 4th, 2018, 2:00pm GMT
Conditions: HER2/Neu Positive; Malignant Neoplasm; Metastatic Malignant Neoplasm in the Brain; Metastatic Malignant Neoplasm in the Leptomeninges
Intervention: Biological: Chimeric Antigen Receptor T-Cell Therapy
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting -
Improving Brain Function After Breast Cancer Study
Posted: October 4th, 2018, 2:00pm GMT
Condition: Breast Cancer Survivors
Interventions: Behavioral: Kirtan Kriya meditation; Behavioral: Music listening program
Sponsor: University of Texas at Austin
Recruiting -
Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients
Posted: October 3rd, 2018, 2:00pm GMT
Condition: Metastatic Colon Cancer
Intervention: Device: Magnetic resonance imaging
Sponsor: Poitiers University Hospital
Not yet recruiting -
A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer
Posted: October 1st, 2018, 2:00pm GMT
Condition: HER2 Positive Metastatic Breast Cancer
Intervention: Drug: Pyrotinib plus Capecitabine
Sponsor: Henan Cancer Hospital
Not yet recruiting -
DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis
Posted: September 26th, 2018, 2:00pm GMT
Conditions: Malignant Neoplasm; Metastatic Malignant Neoplasm in the Brain
Intervention: Procedure: Dual-Energy Computed Tomography
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting -
Non-invasive Glioma Characterization Through Molecular Imaging
Posted: September 25th, 2018, 2:00pm GMT
Conditions: Glioma; Brain Tumor; Primary Brain Tumor; Malignant Glioma; Malignant Primary Brain Tumor
Intervention: Diagnostic Test: 3T MRI Scanner
Sponsor: University of Miami
Not yet recruiting -
Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases
Posted: September 21st, 2018, 2:00pm GMT
Conditions: Invasive Malignant Neoplasm; Metastatic Malignant Neoplasm in the Brain
Interventions: Procedure: Dynamic Susceptibility Contrast-MRI (DSC-MRI); Procedure: Magnetic Resonance Imaging (MRI)
Sponsor: Emory University
Not yet recruiting -
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Posted: September 20th, 2018, 2:00pm GMT
Condition: Glioblastoma
Interventions: Biological: Ad-RTS-hIL-12; Drug: veledimex
Sponsor: Ziopharm
Recruiting -
9-ING-41 in Patients With Advanced Cancers
Posted: September 20th, 2018, 2:00pm GMT
Conditions: Cancer; Lymphoma; Pancreatic Cancer; Glioblastoma Multiforme; Sarcoma; Breast Cancer; Bladder Cancer; Renal Cancer; Ovarian Cancer; Refractory Cancer; Refractory Neoplasm; Refractory Non-Hodgkin Lymphoma; Refractory Brain Tumor; Pancreatic Adenocarcinoma; Resistant Cancer; Neoplasm Metastasis; Neoplasm of Bone; Neoplasm, Breast; Neoplasm of Lung; Neoplasms,Colorectal; Neoplasms Pancreatic; Malignant Glioma; Malignancies; Malignancies Multiple; Bone Metastases; Bone Neoplasm; Bone Cancer; Pancreas Cancer; Pancreatic Neoplasms; Breast Neoplasms
Interventions: Drug: 9-ING-41; Drug: Gemcitabine - 21 day cycle; Drug: Doxorubicin.; Drug: Lomustine; Drug: Carboplatin.; Drug: Nab paclitaxel.; Drug: Paclitaxel.; Drug: Gemcitabine - 28 day cycle
Sponsors: Actuate Therapeutics Inc.; Developmental Therapeutics Consortium
Not yet recruiting -
Spectroscopic Magnetic Resonance Imaging of Glioma
Posted: September 19th, 2018, 2:00pm GMT
Condition: Brain Tumor-Glioma
Intervention: Diagnostic Test: MEGA-PRESS sequence Magnetic Resonance Spectroscopy
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Not yet recruiting -
Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery
Posted: September 19th, 2018, 2:00pm GMT
Condition: Pituitary Neoplasm
Intervention: Device: ENDOSPHENOIDAL COIL
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting -
Nasal Packing Following Endoscopic Endonasal Pituitary Resection
Posted: September 19th, 2018, 2:00pm GMT
Condition: Pituitary Tumor
Intervention: Other: No nasal packing.
Sponsors: Ottawa Hospital Research Institute; The Physicians' Services Incorporated Foundation
Not yet recruiting -
Presence of a Localized or Diffuse Pruritus in a Population With One or Several, Primitive or Secondary, Brain Tumor(s)
Posted: September 17th, 2018, 2:00pm GMT
Conditions: Pruritus; Brain Tumor
Intervention:
Sponsor: University Hospital, Brest
Not yet recruiting -
DM-CHOC-PEN for Brain Tumors in AYA Subjects
Posted: September 13th, 2018, 2:00pm GMT
Conditions: Advanced Cancer; Brain Metastases
Intervention: Drug: DM-CHOC-PEN
Sponsor: DEKK-TEC, Inc.
Not yet recruiting -
Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation
Posted: September 12th, 2018, 2:00pm GMT
Condition: Recurrent IDH1/2 Mutated Glioma
Intervention: Drug: Azacitidine
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting -
Vegetative Monitoring During Brainstem-associated Surgery
Posted: September 11th, 2018, 2:00pm GMT
Conditions: Brain Tumor, Recurrent; Vestibular Schwannoma; Brainstem Neoplasm; Brainstem Glioma
Intervention: Procedure: Intraoperative Monitoring during resection of brain tumor
Sponsor: University Hospital Tuebingen
Recruiting -
BATs in Patients With Breast Cancer and Leptomeningeal Metastases
Posted: September 7th, 2018, 2:00pm GMT
Conditions: Breast Cancer Female; Leptomeningeal Metastases
Intervention: Drug: HER2 BATs
Sponsor: University of Virginia
Not yet recruiting -
Communicating About Sexual Concerns and Dysfunction Effectively (CASCADE) Program
Posted: September 5th, 2018, 2:00pm GMT
Condition: Cancer
Intervention: Behavioral: Communicating About Sexual Concerns and Dysfunction Effectively
Sponsor: Duke University
Recruiting -
Trial of C134 in Patients With Recurrent GBM
Posted: September 5th, 2018, 2:00pm GMT
Conditions: Glioblastoma Multiforme of Brain; Anaplastic Astrocytoma of Brain; Gliosarcoma of Brain
Intervention: Biological: C134
Sponsor: University of Alabama at Birmingham
Not yet recruiting -
Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Posted: August 31st, 2018, 2:00pm GMT
Conditions: Leukemia; Brain Tumor; Solid Tumor; Lymphoma
Interventions: Drug: ALRN-6924; Drug: Cytarabine
Sponsor: Dana-Farber Cancer Institute
Not yet recruiting -
First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System Metastases
Posted: August 31st, 2018, 2:00pm GMT
Conditions: Non-small Cell Lung Cancer; EGFR Gene Mutation; Brain Metastases
Interventions: Drug: AZD3759; Drug: Erlotinib; Drug: Gefitinib
Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd.
Not yet recruiting -
Multi-antigen T Cell Infusion Against Neuro-oncologic Disease
Posted: August 29th, 2018, 2:00pm GMT
Condition: Brain Tumor
Intervention: Biological: TAA-T
Sponsors: Catherine Bollard; Children's Research Institute
Not yet recruiting -
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Posted: August 29th, 2018, 2:00pm GMT
Conditions: Cervical Cancer; Gastric Cancer; Stomach Cancer; Gastroesophageal Junction Cancer; Esophageal Cancer; Hepatocellular Carcinoma; Melanoma; Uveal Melanoma; Merkel Cell Carcinoma; Mesothelioma; MSI; Non-small Cell Lung Cancer; NSCLC; Ovarian Cancer; Squamous Cell Carcinoma of the Head and Neck; Small Cell Lung Cancer; Renal Cell Carcinoma; RCC; Triple-negative Breast Cancer; Urothelial Carcinoma; Mismatch Repair Deficiency
Intervention: Drug: INCAGN02390
Sponsor: Incyte Corporation
Recruiting -
Feasibility of FMISO in Brain Tumors
Posted: August 28th, 2018, 2:00pm GMT
Condition: Malignant Brain Neoplasm
Interventions: Drug: ¹⁸F-Fluoromisonidazole; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography
Sponsors: OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Not yet recruiting -
Avoiding Cardiac Toxicity in Lung Cancer Patients Treated With Curative-intent Radiotherapy
Posted: August 24th, 2018, 2:00pm GMT
Condition: Lung Cancer
Intervention: Diagnostic Test: Blood tests & cardiac imaging
Sponsors: Sally Falk; The Leeds Teaching Hospitals NHS Trust; University of Manchester; University of Leeds; Manchester University NHS Foundation Trust
Not yet recruiting -
To Reduce the Use of Chemotherapy in Elderly Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)
Posted: August 23rd, 2018, 2:00pm GMT
Conditions: Breast Cancer; Estrogen Receptor Positive Tumor; HER2-positive Breast Cancer
Interventions: Drug: Paclitaxel; Drug: Trastuzumab; Drug: Pertuzumab; Drug: Palbociclib; Drug: Letrozole
Sponsors: International Breast Cancer Study Group; Pfizer; Hoffmann-La Roche
Not yet recruiting -
non_invasive_aICP_Tumor
Posted: August 22nd, 2018, 2:00pm GMT
Conditions: Tumor, Brain; Intracranial Pressure Increase
Intervention: Device: Non-invasive measurement of intracranial pressure
Sponsor: Kantonsspital Aarau
Recruiting -
MRI Predictors of Response to Tumor Treating Fields
Posted: August 22nd, 2018, 2:00pm GMT
Condition: Glioblastoma Multiforme
Intervention:
Sponsor: New York Methodist Hospital
Not yet recruiting -
Sunitinib in Sarcomas of the Central Nervous System
Posted: August 22nd, 2018, 2:00pm GMT
Conditions: Gliosarcoma; Central Nervous System Sarcoma
Interventions: Drug: Sunitinib; Device: wGT3x-BT
Sponsor: National Cancer Institute (NCI)
Not yet recruiting -
Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer
Posted: August 20th, 2018, 2:00pm GMT
Conditions: Brain Metastases; Lung Cancer Metastatic; Breast Cancer Metastatic
Intervention: Biological: DCVax-Direct
Sponsors: Northwest Biotherapeutics; Mayo Clinic
Not yet recruiting -
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
Posted: August 20th, 2018, 2:00pm GMT
Conditions: Central Nervous System Tumor, Pediatric; Glioma; Ependymoma; Medulloblastoma; Germ Cell Tumor; Atypical Teratoid/Rhabdoid Tumor; Primitive Neuroectodermal Tumor; Choroid Plexus Carcinoma; Pineoblastoma
Intervention: Biological: EGFR806-specific chimeric antigen receptor (CAR) T cell
Sponsor: Seattle Children's Hospital
Not yet recruiting -
Eribulin in Brain Metastases From HER2-negative Breast Cancer
Posted: August 20th, 2018, 2:00pm GMT
Condition: Metastatic Breast Cancer
Intervention: Drug: Eribulin
Sponsors: Institut Paoli-Calmettes; Eisai Inc.
Not yet recruiting -
Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy
Posted: August 17th, 2018, 2:00pm GMT
Condition: Refractory Epilepsy
Interventions: Drug: Perampanel; Drug: conventional antiepileptic treatment
Sponsor: Assistance Publique Hopitaux De Marseille
Not yet recruiting -
A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
Posted: August 17th, 2018, 2:00pm GMT
Condition: Glioblastoma
Interventions: Biological: Ad-RTS-hIL-12; Drug: veledimex; Drug: Nivolumab
Sponsor: Ziopharm
Recruiting -
Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)
Posted: August 17th, 2018, 2:00pm GMT
Conditions: Hyponatremia; Hyponatremic; Pituitary Tumor; Pituitary; Surgery
Intervention: Other: Fluid Restricted Group
Sponsor: Washington University School of Medicine
Recruiting -
Pilot Imaging Study of Leukemia
Posted: August 16th, 2018, 2:00pm GMT
Condition: Acute Leukemia
Intervention: Drug: FLT imaging
Sponsor: Children's Research Institute
Recruiting -
Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma
Posted: August 15th, 2018, 2:00pm GMT
Condition: Recurrent Glioblastoma
Interventions: Diagnostic Test: ChemoID assay; Drug: Chemotherapy
Sponsor: Cordgenics, LLC
Recruiting -
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
Posted: August 14th, 2018, 2:00pm GMT
Conditions: Glioblastoma; Glioblastoma Multiforme; GBM; Brain Cancer
Intervention: Procedure: Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
Sponsor: Northwell Health
Recruiting -
Study to Develop Head Stabilizer for Use During Brain Radiation Therapy
Posted: August 14th, 2018, 2:00pm GMT
Conditions: Brain Diseases; Brain Cancer
Interventions: Device: Wiersma Head Stabilizer; Device: AlignRT system
Sponsor: University of Chicago
Recruiting -
Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors
Posted: August 14th, 2018, 2:00pm GMT
Conditions: Relapsed Pediatric Solid Tumor; Refractory Pediatric Solid Tumor
Interventions: Drug: Pazopanib; Drug: Ifosfamide; Drug: Carboplatin; Drug: Etoposide
Sponsors: Samsung Medical Center; Ministry of Health, Republic of Korea
Not yet recruiting -
The Impact of Neurocognitive Function in Patients With Multiple Brain Metastases Receiving Whole Brain Radiation Therapy
Posted: August 13th, 2018, 2:00pm GMT
Condition: Brain Metastases
Intervention:
Sponsor: Guangdong Association of Clinical Trials
Not yet recruiting -
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
Posted: August 13th, 2018, 2:00pm GMT
Conditions: Glioblastoma Multiforme; Brain Tumor; Glioblastoma; Glioma; Neoplasms; Neoplasms, Nerve Tissue
Intervention: Device: NaviFUS System
Sponsors: NaviFUS Corporation; Chang Gung Memorial Hospital
Recruiting -
Prediction of Sphenoid Septation in MRI Compared With CT and Intraoperative Findings During Endoscopic Pituitary Adenoma Surgery
Posted: August 9th, 2018, 2:00pm GMT
Condition: Pituitary Adenoma
Intervention: Procedure: comparison of data from MRI with data from CT compared with intraoperative data from endoscopic pituitary adenoma surgery
Sponsor: University Hospital, Basel, Switzerland
Recruiting -
Role of MR Spectroscopy in Brain Tumors
Posted: August 8th, 2018, 2:00pm GMT
Condition: Brain Neoplasms
Intervention: Device: MRI Spectroscopy
Sponsor: Assiut University
Recruiting -
Randomized Control Trial for Awake vs. Asleep Craniotomy for Non-eloquent Gliomas
Posted: August 8th, 2018, 2:00pm GMT
Condition: Intracranial Glioma
Interventions: Procedure: Awake Anesthesia Protocol; Procedure: Non-awake Anesthesia Protocol
Sponsor: Mayo Clinic
Not yet recruiting -
Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer
Posted: August 7th, 2018, 2:00pm GMT
Condition: Breast Cancer
Interventions: Other: SAE battery; Behavioral: Assessments
Sponsors: Memorial Sloan Kettering Cancer Center; The City College of New York
Recruiting -
Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer
Posted: August 6th, 2018, 2:00pm GMT
Conditions: Metastatic Breast Cancer With HER2 Positive; Triple Negative Breast Cancer
Intervention: Procedure: Brain MRI
Sponsor: Yonsei University
Not yet recruiting -
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
Posted: August 6th, 2018, 2:00pm GMT
Condition: Glioblastoma
Intervention: Device: Focused Ultrasound (FUS) BBB Disruption
Sponsor: InSightec
Recruiting -
Predictive Role and HuR Mechanisms of Regulation in the Brain Tumours
Posted: August 3rd, 2018, 2:00pm GMT
Condition: Brain Tumours
Intervention:
Sponsor: Central Hospital, Nancy, France
Recruiting -
The Effect of Vitamin D3 on Postoperative Pain in Patients Undergoing Craniotomy
Posted: August 3rd, 2018, 2:00pm GMT
Condition: Brain Neoplasms
Intervention: Drug: vitamin D
Sponsor: Shahid Beheshti University
Recruiting -
Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients With Newly Diagnosed Glioblastoma, Recurrent Malignant Glioma or Recurrent Medulloblastoma
Posted: August 3rd, 2018, 2:00pm GMT
Conditions: Glioblastoma; Malignant Glioma; Medulloblastoma Recurrent; Pediatric Glioblastoma Multiforme; Pediatric Brain Tumor, Recurrent; Pediatric Brain Tumor
Interventions: Biological: CMV-DCs with GM-CSF; Biological: Td (tetanus toxoid)
Sponsors: Gary Archer Ph.D.; National Institutes of Health (NIH)
Recruiting -
ANG1005 in Leptomeningeal Disease From Breast Cancer
Posted: August 3rd, 2018, 2:00pm GMT
Conditions: Leptomeningeal Carcinomatosis; Leptomeningeal Metastases; Brain Metastases; HER2-negative Breast Cancer
Interventions: Drug: ANG1005; Drug: Physician's Best Choice
Sponsor: Angiochem Inc
Not yet recruiting -
Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC
Posted: August 3rd, 2018, 2:00pm GMT
Condition: Non-small Cell Lung Cancer
Interventions: Drug: endostar; Drug: Placebos; Radiation: radiotherapy
Sponsor: Wuhan Union Hospital, China
Recruiting -
Neurocognitive Risks in Children With Solid Tumors
Posted: August 1st, 2018, 2:00pm GMT
Condition: Solid Tumor in Children
Interventions: Other: The WISC-IV; Other: The CMS (CHILD MEMORY SCALE); Other: CONNERS; Other: BRIEF; Other: PEDS-QL; Other: State Trait Anxiety Inventory; Other: Child Depression Inventory
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Recruiting -
A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy
Posted: July 31st, 2018, 2:00pm GMT
Condition: Multiple Brain Metastases
Interventions: Drug: BMX-001; Radiation: Whole Brain Radiation Therapy
Sponsors: BioMimetix JV, LLC; Duke Cancer Institute; National Cancer Institute (NCI)
Recruiting -
Tumor-Treating Fields Therapy in Preventing Brain Tumors in Participants With Extensive-Stage Small Cell Lung Cancer
Posted: July 31st, 2018, 2:00pm GMT
Condition: Extensive Stage Small Cell Lung Carcinoma
Interventions: Procedure: Tumor Treating Fields (TTF) Therapy; Device: NovoTTF-200A Device; Other: Quality-of-Life Assessment
Sponsors: Albert Attia; NovoCure Ltd.
Recruiting -
Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Grade II-IV Brain Tumors
Posted: July 30th, 2018, 2:00pm GMT
Condition: Brain Neoplasm
Interventions: Other: Questionnaire Administration; Procedure: Transcranial Magnetic Stimulation
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting -
A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma
Posted: July 30th, 2018, 2:00pm GMT
Conditions: High Grade Glioma; Diffuse Intrinsic Pontine Glioma
Interventions: Drug: PTC596; Radiation: Radiotherapy
Sponsors: Children's Hospital Medical Center, Cincinnati; PTC Therapeutics
Recruiting -
CBF and NCF Changes With Brain Radiation
Posted: July 30th, 2018, 2:00pm GMT
Conditions: Neurocognitive Dysfunction; Brain Metastases
Interventions: Radiation: SRS and neurocognitive assessments; Radiation: WBRT and neurocognitive assessments
Sponsor: University Health Network, Toronto
Recruiting -
Evaluation of Preoperative Functional Magnetic Resonance Imaging (fMRI) in Patients With Brain Tumors
Posted: July 27th, 2018, 2:00pm GMT
Condition: Brain Tumor
Intervention: Device: fMRI Paradigms
Sponsors: Memorial Sloan Kettering Cancer Center; Weill Medical College of Cornell University
Recruiting -
A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia
Posted: July 26th, 2018, 2:00pm GMT
Conditions: Fanconi Anemia; Myelodysplastic Syndrome (MDS); Acute Myelogenous Leukemia (AML)
Interventions: Drug: Busulfan; Drug: Fludarabine; Drug: Cyclophosphamide; Drug: Anti-Thymocyte Globulin (Rabbit); Device: The CliniMACS device; Drug: G-CSF
Sponsors: Memorial Sloan Kettering Cancer Center; Pediatric Brain Tumor Consortium
Recruiting -
Volitinib in Treating Participants With Recurrent or Refractory Primary CNS Tumors
Posted: July 25th, 2018, 2:00pm GMT
Conditions: MET Fusion Gene Positive; MET Gene Mutation; Primary Central Nervous System Neoplasm; Progressive Medulloblastoma; Recurrent Diffuse Intrinsic Pontine Glioma; Recurrent Malignant Glioma; Recurrent Medulloblastoma; Refractory Diffuse Intrinsic Pontine Glioma; Refractory Malignant Glioma; Refractory Medulloblastoma
Intervention: Drug: Savolitinib
Sponsor: National Cancer Institute (NCI)
Not yet recruiting -
Trial of Parotid Sparing Whole Brain Radiation
Posted: July 23rd, 2018, 2:00pm GMT
Condition: Xerostomia
Interventions: Radiation: Parotid sparing WBRT; Radiation: Standard WBRT
Sponsors: UNC Lineberger Comprehensive Cancer Center; UNC Department of Radiation Oncology
Recruiting -
Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis
Posted: July 19th, 2018, 2:00pm GMT
Condition: Pediatric Brain Tumor
Interventions: Procedure: Ketogenic diet; Drug: BCNU
Sponsor: Washington University School of Medicine
Not yet recruiting -
Dose and Volume Escalation of Preoperative Brain Irradiation in GBM Patients -the POBIG Trial -
Posted: July 11th, 2018, 2:00pm GMT
Condition: Glioblastoma Multiforme
Intervention: Radiation: Preoperative brain irradiation (single fraction)
Sponsor: The Netherlands Cancer Institute
Not yet recruiting -
Effect of Exercise on Cancer-Related Fatigue
Posted: July 3rd, 2018, 2:00pm GMT
Conditions: Cancer-related Problem/Condition; Exercise
Interventions: Behavioral: TEHE only; Behavioral: Auricular Point Acupressure; Behavioral: Mindfulness body scan
Sponsor: Johns Hopkins University
Not yet recruiting -
Magnesium Sulphate Versus Lidocaine for Control of Emergence Hypertension
Posted: June 25th, 2018, 2:00pm GMT
Conditions: Craniotomy; Hypertension
Interventions: Drug: Magnesium sulphate; Drug: Lidocaine Hydrochloride; Drug: Normal saline
Sponsor: Ahmed Mohamed ELbadawy
Recruiting -
Hypofractionated Brain Radiationcavity
Posted: June 19th, 2018, 2:00pm GMT
Conditions: Brain Metastases, Adult; Cancer Brain
Interventions: Radiation: IGRT; Radiation: SRS
Sponsor: Oncology Institute of Southern Switzerland
Recruiting -
Stereotactic Radiosurgery Compared With Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases
Posted: June 8th, 2018, 2:00pm GMT
Condition: Brain Metastases
Interventions: Drug: Memantine; Radiation: Whole Brain Radiotherapy (WBRT); Procedure: Stereotactic Radiosurgery (SRS)
Sponsors: Canadian Cancer Trials Group; Alliance for Clinical Trials in Oncology
Recruiting -
Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children With High Grade Brain Tumors and Their Caregivers
Posted: May 28th, 2018, 2:00pm GMT
Conditions: Gliomas; Glioblastomas; Astrocytoma; Brain Neoplasm; Brain Cancer
Interventions: Behavioral: Enhanced Mindfulness Intervention; Behavioral: Psychoeducation
Sponsor: National Cancer Institute (NCI)
Recruiting -
[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
Posted: May 28th, 2018, 2:00pm GMT
Conditions: Healthy Subject; Intracranial Neoplasm; Recurrent Glioblastoma
Interventions: Drug: Fluorine F 18 DASA-23; Procedure: Positron Emission Tomography
Sponsor: Sanjiv Sam Gambhir
Recruiting -
Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Posted: May 24th, 2018, 2:00pm GMT
Condition: Glioblastoma
Interventions: Drug: Ibrutinib; Radiation: Radiation; Drug: Temozolomide (TMZ)
Sponsor: Case Comprehensive Cancer Center
Recruiting -
Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis
Posted: May 16th, 2018, 2:00pm GMT
Condition: Non-small Cell Lung Cancer Stage IV
Intervention: Drug: Atezolizumab
Sponsor: Spanish Lung Cancer Group
Recruiting -
Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer
Posted: May 10th, 2018, 2:00pm GMT
Conditions: KRAS Gene Mutation; Metastatic Malignant Neoplasm in the Brain; Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer AJCC v7
Interventions: Drug: Methotrexate; Other: Pharmacokinetic Study; Drug: Regorafenib
Sponsor: Stanford University
Recruiting -
Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases
Posted: May 9th, 2018, 2:00pm GMT
Condition: Leptomeningeal Metastases
Intervention: Radiation: Proton craniospinal irradiation (CSI)
Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting -
Endocrine Outcome of Surgery for Pituitary Adenoma
Posted: May 3rd, 2018, 2:00pm GMT
Condition: Pituitary Adenoma
Interventions: Procedure: Endoscopic resection; Procedure: Microsurgical resection
Sponsor: University of Ulm
Recruiting -
Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating Fields
Posted: April 17th, 2018, 2:00pm GMT
Condition: Malignant Glioma
Intervention: Device: NovoTTF
Sponsors: Duke University; NovoCure Ltd.
Recruiting -
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
Posted: April 17th, 2018, 2:00pm GMT
Conditions: Central Nervous System Tumor, Pediatric; Glioma; Ependymoma; Medulloblastoma; Germ Cell Tumor; Atypical Teratoid/Rhabdoid Tumor; Primitive Neuroectodermal Tumor; Choroid Plexus Carcinoma; Pineoblastoma
Intervention: Biological: HER2-specific chimeric antigen receptor (CAR) T cell
Sponsor: Seattle Children's Hospital
Recruiting -
Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently
Posted: April 12th, 2018, 2:00pm GMT
Conditions: Glioma; Glioma of Brain; Glioma of Spinal Cord
Interventions: Behavioral: Multilingual Aphasia Examination; Diagnostic Test: Language paradigms + RS fMRI; Diagnostic Test: Language paradigms + RS fMRI + one anatomical sequence
Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting -
Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade
Posted: April 11th, 2018, 2:00pm GMT
Condition: Glioblastoma
Interventions: Drug: Nivolumab; Drug: BMS-986016
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting -
INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
Posted: April 9th, 2018, 2:00pm GMT
Condition: Glioblastoma
Interventions: Biological: INO-5401; Biological: INO-9012; Biological: Cemiplimab; Radiation: Radiation Therapy; Drug: Temozolomide
Sponsor: Inovio Pharmaceuticals
Recruiting -
Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain
Posted: April 5th, 2018, 2:00pm GMT
Conditions: Brain Metastases; Small Cell Lung Cancer
Interventions: Device: NovoTTF-200A; Radiation: Stereotactic Radiosurgery (SRS)
Sponsors: Drexell Hunter Boggs; NovoCure Ltd.
Not yet recruiting -
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
Posted: March 23rd, 2018, 2:00pm GMT
Conditions: Glioblastoma; Radiotherapy; Complications; Cognitive Decline; Chemoradiation
Intervention: Drug: Ramipril
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Not yet recruiting -
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
Posted: March 7th, 2018, 3:00pm GMT
Conditions: Pituitary Adenoma; Prolactinoma; Pituitary Tumor; Recurrence Tumor
Intervention: Drug: Cabergoline
Sponsor: Seoul National University Hospital
Not yet recruiting -
A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)
Posted: March 6th, 2018, 3:00pm GMT
Conditions: Cancer; Pediatric Solid Tumor; Pediatric AML; Pediatric ALL
Intervention: Drug: PEG- BCT-100
Sponsor: University of Birmingham
Recruiting -
EDO-S101 for MGMT Unmethylated Glioblastoma (nGBM)
Posted: March 2nd, 2018, 3:00pm GMT
Conditions: Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System; Unmethylated Glioblastoma
Interventions: Drug: EDO-S101; Radiation: Radiation Therapy
Sponsors: M.D. Anderson Cancer Center; Mundipharma-EDO GmbH
Recruiting -
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
Posted: February 8th, 2018, 3:00pm GMT
Conditions: Glioblastoma; Brain Tumor; GBM
Interventions: Drug: Pembrolizumab; Drug: Vorinostat; Drug: Temozolomide; Radiation: Radiotherapy
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Merck Sharp & Dohme Corp.
Recruiting -
A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer
Posted: February 7th, 2018, 3:00pm GMT
Condition: Newly Diagnosed Glioblastoma
Interventions: Drug: Temozolomide; Radiation: conformal brain radiation therapy; Drug: Nivolumab; Drug: Ipilimumab
Sponsor: John Wayne Cancer Institute
Recruiting -
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Posted: February 6th, 2018, 3:00pm GMT
Conditions: Recurrent Glioblastoma Multiforme; Primary Glioblastoma Multiforme; Brain Neoplasms, Malignant; Leptomeningeal Disease (LMD)
Interventions: Radiation: Radiation Therapy; Drug: AZD1390
Sponsor: AstraZeneca
Recruiting -
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Posted: February 1st, 2018, 3:00pm GMT
Conditions: Cardiotoxicity; HER2/Neu Positive; Metastatic Malignant Neoplasm in the Brain; Recurrent Breast Carcinoma; Stage IV Breast Cancer AJCC v6 and v7
Interventions: Drug: Carvedilol; Other: Laboratory Biomarker Analysis; Other: Patient Observation
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting